John P. Mueller
NKT Therapeutics (United States)
ORCID: 0000-0001-9368-4015Also affiliated with Innoviva (United States)
Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicineEnvironmental Science
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 3 papers. Top paper: “Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Neisseria gonorrhoeae Clinical Isolates in Nanjing, China, 2014 to 2018”.
27 citations
Xiaohong Su, Xiangdi Lou, Xuechun Li, Xiangdong Gong, Baoxi Wang +4 more
0 citations
Xiaohong Su, Xiangdi Lou, Xuechun Li, Xiangdong Gong, Baoxi Wang +4 more
N/A
54 citations
Nicole A. P. Lieberman, Clara Pérez‐Mañá, Clara Suñer, Martí Vall Mayans, María Ubals +10 more